PRL and breast cancer: Following the line of reasoning that prolactin acts as a survival factor in breast cancer cells [59-63] and that STAT5 promotes survival in normal mammary epithelial cells [64,65], we tested whether the addition of prolactin to starved, untransformed mammary epithelial HC11 cells would rescue differentiated cells from apoptosis.